AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16053592 — intervention group
Group type: COMPARATOR
Intervention: Standard inpatient hospital care
Number of subjects: 285
Study 11974642 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention condition
Number of subjects: 3104
Study 11974642 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 3104
Study 9860382 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands-on classroom experience with low-fat foods
Number of subjects: 0
Study 9860382 — intervention group
Group type: COMPARATOR
Intervention: No classroom experience (Control)
Number of subjects: 0
Study 7637536 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol ingestion (2.9 to 3.1 g/kg/d) with large volume of fluid (39.2 or 51.1 ml/kg/d)
Number of subjects: 0
Study 7637536 — intervention group
Group type: COMPARATOR
Intervention: Fluid intake without glycerol
Number of subjects: 0
Study 2497890 — intervention group
Group type: EXPERIMENTAL
Intervention: Latex agglutination test specific for serotype of pneumococcal antigen
Number of subjects: 101
Study 2497890 — intervention group
Group type: COMPARATOR
Intervention: Control group (102 children without pneumonia)
Number of subjects: 101
Study 576817 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard tablet formulation (5 mg)
Number of subjects: 0
Study 576817 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release capsule formulation (20 mg)
Number of subjects: 0
Study 30522504 — intervention group
Group type: EXPERIMENTAL
Intervention: Thread-embedding acupuncture (TEA) with polydioxanone thread at 14 fixed acupoints, treatment once a week for 4 sessions
Number of subjects: 50
Study 30522504 — intervention group
Group type: COMPARATOR
Intervention: Sham TEA with a sham device (thread removed), treatment once a week for 4 sessions
Number of subjects: 50
Study 30522504 — intervention group
Group type: EXPERIMENTAL
Intervention: Thread-embedding acupuncture (TEA)
Number of subjects: 50
Study 27400005 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg oral sildenafil citrate every 8 hours
Number of subjects: 100
Study 27400005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 23431960 — intervention group
Group type: EXPERIMENTAL
Intervention: Cylindrical implants (Group A)
Number of subjects: 76
Study 23431960 — intervention group
Group type: EXPERIMENTAL
Intervention: Conical/cylindrical implants (Group B)
Number of subjects: 76
Study 23431960 — intervention group
Group type: EXPERIMENTAL
Intervention: Both implant types
Number of subjects: 76
Study 22005217 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron 0.25 mg IV plus dexamethasone 8 mg IV on day 1
Number of subjects: 324
Study 22005217 — intervention group
Group type: COMPARATOR
Intervention: Palonosetron 0.25 mg IV plus dexamethasone 8 mg IV on day 1 followed by oral dexamethasone 8 mg on days 2 and 3
Number of subjects: 324
Study 21063118 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 8 mg once daily for 3-6 weeks before cardioversion and 16 mg once daily for 6 months after cardioversion
Number of subjects: 98
Study 21063118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 19036172 — intervention group
Group type: EXPERIMENTAL
Intervention: M-inflated trials under the random effects model
Number of subjects: 157
Study 19036172 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 157
Study 15522993 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid + heparin emulsion
Number of subjects: 7
Study 15522993 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 7
Study 11823085 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin receptor blockers (ARBs)
Number of subjects: 12469
Study 11823085 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy of ARBs and ACEIs
Number of subjects: 12469
Study 10099031 — intervention group
Group type: EXPERIMENTAL
Intervention: Superior oblique tendon resection only (n = 14)
Number of subjects: 195
Study 10099031 — intervention group
Group type: EXPERIMENTAL
Intervention: Superior oblique tendon resection or inferior oblique recession (n = 181)
Number of subjects: 195
Study 8087727 — intervention group
Group type: EXPERIMENTAL
Intervention: Saizen (0.2 IU/kg sc tiw)
Number of subjects: 15
Study 8087727 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotropin (0.1 IU/kg sc qd)
Number of subjects: 15
Study 8087727 — intervention group
Group type: EXPERIMENTAL
Intervention: Humatrope (0.1 IU/kg sc qd)
Number of subjects: 15
Study 2678858 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term antibiotic prophylaxis (cefotaxime for biliary or gastric, gentamicin/metronidazole for colorectal)
Number of subjects: 750
Study 2678858 — intervention group
Group type: COMPARATOR
Intervention: Long-term antibiotic prophylaxis (cefotaxime for biliary or gastric, gentamicin/metronidazole for colorectal)
Number of subjects: 750
Study 2678858 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with preoperative scores less than 5
Number of subjects: 750
Study 2678858 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with preoperative scores greater than or equal to 5
Number of subjects: 750
Study 1093498 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentaeritritol administered for 4 weeks
Number of subjects: 24
Study 1093498 — intervention group
Group type: COMPARATOR
Intervention: Dipridamol
Number of subjects: 24
Study 30772849 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra in addition to intravenous corticosteroid treatment
Number of subjects: 214
Study 30772849 — intervention group
Group type: COMPARATOR
Intervention: Placebo in addition to intravenous corticosteroid treatment
Number of subjects: 214
Study 28380315 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-Intensity Conditioning (RIC)
Number of subjects: 272
Study 28380315 — intervention group
Group type: COMPARATOR
Intervention: Myeloablative Conditioning (MAC)
Number of subjects: 272
Study 26364528 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing self-management program (12-week program: 8 weeks group motivational interviewing and education, 4 weeks individual motivational interviewing on the phone)
Number of subjects: 42
Study 26364528 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 42
Study 23376004 — intervention group
Group type: EXPERIMENTAL
Intervention: LBTM (lansoprazole 30 mg twice daily, bismuth potassium citrate 220 mg twice daily, tetracycline 500 mg 4 times daily, metronidazole 400 mg 4 times daily)
Number of subjects: 424
Study 23376004 — intervention group
Group type: EXPERIMENTAL
Intervention: LBTF (tetracycline 500 mg 3 times daily, furazolidone 100 mg 3 times daily)
Number of subjects: 424
Study 23376004 — intervention group
Group type: EXPERIMENTAL
Intervention: LBAT (amoxicillin 1000 mg 3 times daily, tetracycline 500 mg 4 times daily)
Number of subjects: 424
Study 23376004 — intervention group
Group type: EXPERIMENTAL
Intervention: LBAF (amoxicillin 1000 mg 3 times daily, furazolidone 100 mg 3 times daily)
Number of subjects: 424
Study 23376004 — intervention group
Group type: COMPARATOR
Intervention: Furazolidone-containing regimens (LBTF, LBAF)
Number of subjects: 424
Study 23376004 — intervention group
Group type: COMPARATOR
Intervention: LBTM
Number of subjects: 424
Study 21228087 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care patient assessment and advance care planning (ACP) intervention
Number of subjects: 33
Study 21228087 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 33
Study 19709060 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately rough (tioblasted) titanium implants
Number of subjects: 20
Study 19709060 — intervention group
Group type: COMPARATOR
Intervention: Minimally rough machined/turned surfaces
Number of subjects: 20
Study 19709060 — intervention group
Group type: EXPERIMENTAL
Intervention: Both implant surfaces (tioblasted and turned)
Number of subjects: 20
Study 18095528 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of nurse practitioners (NPs) and a pharmacist into the care team
Number of subjects: 120
Study 18095528 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing monitoring at home by nurse practitioners (NPs)
Number of subjects: 120
Study 18095528 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall integration of nurse practitioners (NPs) into the multidisciplinary team
Number of subjects: 120
Study 15154857 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic daily headache
Number of subjects: 40
Study 15154857 — intervention group
Group type: EXPERIMENTAL
Intervention: Common analgesic use
Number of subjects: 40
Study 11866419 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (20 minutes of preselected music)
Number of subjects: 101
Study 11866419 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 101
Study 9516221 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 29
Study 9516221 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone
Number of subjects: 29
Study 9516221 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Metformin and Troglitazone
Number of subjects: 29
Study 7750809 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa methyl ester (LDME) 250 mg
Number of subjects: 25
Study 7750809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 29274540 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise training for 24 weeks
Number of subjects: 60
Study 29274540 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control group
Number of subjects: 60
Study 26714658 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 0
Study 26714658 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 25052227 — intervention group
Group type: COMPARATOR
Intervention: High oleic acid sunflower oil (HOS)
Number of subjects: 53
Study 25052227 — intervention group
Group type: COMPARATOR
Intervention: Interesterified palm olein (IPO)
Number of subjects: 53
Study 25052227 — intervention group
Group type: COMPARATOR
Intervention: Palm olein (PO)
Number of subjects: 53
Study 23258457 — intervention group
Group type: EXPERIMENTAL
Intervention: Room-air TCOM measurements
Number of subjects: 32
Study 23258457 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing 100% oxygen
Number of subjects: 32
Study 23258457 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold for tissue hypoxia
Number of subjects: 32
Study 23258457 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommended TCOM values for tissue hypoxia
Number of subjects: 32
Study 20876468 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 150
Study 20876468 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 150
Study 18165594 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine 4 microg/mL added to ropivacaine 1.8 mg/mL and fentanyl 3 microg/mL (group RFE)
Number of subjects: 63
Study 18165594 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 1.8 mg/mL and fentanyl 3 microg/mL without epinephrine (group RF)
Number of subjects: 63
Study 16087692 — intervention group
Group type: EXPERIMENTAL
Intervention: ESFA programme (experimental group)
Number of subjects: 10751
Study 16087692 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10751
Study 12902321 — intervention group
Group type: EXPERIMENTAL
Intervention: Depletion CHO-loading protocol (D group) with 120-min cycle exercise at 65% VO2 peak followed by 1-min sprints at 120% VO2 peak to exhaustion.
Number of subjects: 25
Study 12902321 — intervention group
Group type: COMPARATOR
Intervention: Nondepletion CHO-loading protocol (ND group) with 20-min cycle exercise at 65% VO2 peak.
Number of subjects: 25
Study 11153293 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone cuff tracheostomy tube
Number of subjects: 12
Study 11153293 — intervention group
Group type: COMPARATOR
Intervention: Shiley cuffed tracheostomy tube
Number of subjects: 12
Study 9326900 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular long-bar overdenture supported by 4 implants
Number of subjects: 16
Study 9326900 — intervention group
Group type: COMPARATOR
Intervention: Two-implant hybrid overdenture
Number of subjects: 16
Study 8472518 — intervention group
Group type: EXPERIMENTAL
Intervention: ST-679 (1200 mg per day)
Number of subjects: 160
Study 8472518 — intervention group
Group type: COMPARATOR
Intervention: Tolmetin (1200 mg per day)
Number of subjects: 160
Study 2951801 — intervention group
Group type: EXPERIMENTAL
Intervention: Duovent (200 micrograms fenoterol + 80 micrograms ipratropium bromide)
Number of subjects: 14
Study 2951801 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbuterol (200 micrograms active substance)
Number of subjects: 14
Study 2951801 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 30744914 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexketoprofen (50 mg)
Number of subjects: 200
Study 30744914 — intervention group
Group type: COMPARATOR
Intervention: Intravenous paracetamol (1000 mg)
Number of subjects: 200
Study 29356339 — intervention group
Group type: EXPERIMENTAL
Intervention: Active psychoeducational intervention (AP)
Number of subjects: 43
Study 29356339 — intervention group
Group type: COMPARATOR
Intervention: Passive psychoeducational intervention (PP)
Number of subjects: 43
Study 27236813 — intervention group
Group type: EXPERIMENTAL
Intervention: Intelligent Physical Exercise Training (IPET) - 1 hour supervised high intensity training every week for 1 year, plus recommendation for 30 minutes of moderate intensity physical activity 6 days a week during leisure.
Number of subjects: 389
Study 27236813 — intervention group
Group type: EXPERIMENTAL
Intervention: Intelligent Physical Exercise Training (IPET) - adherence of ≥70%.
Number of subjects: 389
Study 27236813 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - no specific intervention mentioned.
Number of subjects: 389
Study 25224239 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% hypertonic saline (HS)
Number of subjects: 124
Study 25224239 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% hypertonic saline (HS)
Number of subjects: 124
Study 25224239 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline (NS)
Number of subjects: 124
Study 22986277 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Freedom Techniques (EFT)
Number of subjects: 83
Study 22986277 — intervention group
Group type: COMPARATOR
Intervention: Supportive Interviews (SI)
Number of subjects: 83
Study 22986277 — intervention group
Group type: COMPARATOR
Intervention: No Treatment (NT)
Number of subjects: 83
Study 20516223 — intervention group
Group type: EXPERIMENTAL
Intervention: Spaced practice
Number of subjects: 0
Study 20516223 — intervention group
Group type: EXPERIMENTAL
Intervention: Massed practice
Number of subjects: 0
Study 20516223 — intervention group
Group type: COMPARATOR
Intervention: Initial study trial
Number of subjects: 0
Study 18021599 — intervention group
Group type: EXPERIMENTAL
Intervention: Moisturizers with MDBGN at 0.03% w/w
Number of subjects: 38
Study 18021599 — intervention group
Group type: COMPARATOR
Intervention: Moisturizers without MDBGN
Number of subjects: 38
Study 16095961 — intervention group
Group type: EXPERIMENTAL
Intervention: Secure messaging system
Number of subjects: 200
Study 16095961 — intervention group
Group type: COMPARATOR
Intervention: Standard care without access to messaging system
Number of subjects: 200
Study 12429074 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine system (LNG‐IUS)
Number of subjects: 0
Study 12429074 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine system (LNG‐IUS) with estrogen
Number of subjects: 0
Study 10513351 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (200 micrograms/dose q.i.d.)
Number of subjects: 32
Study 10513351 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (200 micrograms/dose q.i.d.)
Number of subjects: 32
Study 10513351 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate
Number of subjects: 32
Study 7561195 — intervention group
Group type: EXPERIMENTAL
Intervention: Peru-15 vaccine (2 x 10^8 cfu)
Number of subjects: 11
Study 7561195 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 11
Study 2324896 — intervention group
Group type: EXPERIMENTAL
Intervention: L-ascorbic acid (AA) 284 mumol (50 mg) twice daily
Number of subjects: 6
Study 2324896 — intervention group
Group type: COMPARATOR
Intervention: Control (without AA)
Number of subjects: 6
Study 400464 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 0
Study 400464 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31108273 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 18556
Study 27322609 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 160
Study 25918644 — intervention group
Group type: EXPERIMENTAL
Intervention: 17-week weight loss program followed by a one-year maintenance program
Number of subjects: 201
Study 25918644 — intervention group
Group type: COMPARATOR
Intervention: 17-week weight loss program without subsequent maintenance intervention
Number of subjects: 201
Study 24238346 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week minimally guided web-based self-help program
Number of subjects: 260
Study 24238346 — intervention group
Group type: COMPARATOR
Intervention: Online psychoeducation program on depression
Number of subjects: 260
Study 21035909 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation (APC) tonsillectomy, n = 109
Number of subjects: 218
Study 21035909 — intervention group
Group type: COMPARATOR
Intervention: Conventional tonsillectomy, n = 109
Number of subjects: 218
Study 19584830 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sulfate solution
Number of subjects: 772
Study 19584830 — intervention group
Group type: COMPARATOR
Intervention: PEG‐EA regimen
Number of subjects: 772
Study 19584830 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sulfate solution (split-dose)
Number of subjects: 772
Study 19584830 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sulfate solution (1-day preparation)
Number of subjects: 772
Study 19584830 — intervention group
Group type: COMPARATOR
Intervention: PEG‐EA (1-day preparation)
Number of subjects: 772
Study 19584830 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sulfate solution and PEG‐EA
Number of subjects: 772
Study 16905562 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pathway implementation (post-implementation group)
Number of subjects: 267
Study 16905562 — intervention group
Group type: COMPARATOR
Intervention: Pre-implementation control group
Number of subjects: 267
Study 15136366 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib, 25 mg/d plus aspirin 100 mg/d
Number of subjects: 34
Study 15136366 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus aspirin 100 mg/d
Number of subjects: 34
Study 11295882 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood-brain ratios (BBR) of phenylalanine (Phe) measured by 1H magnetic resonance spectroscopy (1H‐MRS)
Number of subjects: 17
Study 11295882 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Phe values
Number of subjects: 17
Study 11295882 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term dietary control
Number of subjects: 17
Study 11295882 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluctuation of blood Phe values during treatment
Number of subjects: 17
Study 11295882 — intervention group
Group type: EXPERIMENTAL
Intervention: High blood and brain Phe concentrations
Number of subjects: 17
Study 11295882 — intervention group
Group type: EXPERIMENTAL
Intervention: BBR values, intelligence quotient, and MRI grade
Number of subjects: 17
Study 10920905 — intervention group
Group type: EXPERIMENTAL
Intervention: N-CWS
Number of subjects: 45
Study 10920905 — intervention group
Group type: COMPARATOR
Intervention: MMC
Number of subjects: 45
Study 18476202 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocautery subcutaneous incision
Number of subjects: 380
Study 18476202 — intervention group
Group type: COMPARATOR
Intervention: Scalpel subcutaneous incision
Number of subjects: 380
Study 18476202 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 380
Study 18476202 — intervention group
Group type: EXPERIMENTAL
Intervention: Infection
Number of subjects: 380
Study 18476202 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors
Number of subjects: 380
Study 3826196 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine activity monitor
Number of subjects: 67
Study 3826196 — intervention group
Group type: COMPARATOR
Intervention: Palpation (Control)
Number of subjects: 67
Study 31640847 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle plantar-flexed during static stretching
Number of subjects: 14
Study 31640847 — intervention group
Group type: COMPARATOR
Intervention: Ankle dorsiflexed during static stretching
Number of subjects: 14
Study 29154073 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous extract of edible dried fig fruit applied twice a day for two weeks
Number of subjects: 45
Study 29154073 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone 1.0% applied twice a day for two weeks
Number of subjects: 45
Study 29154073 — intervention group
Group type: COMPARATOR
Intervention: Base cream (placebo) applied twice a day for two weeks
Number of subjects: 45
Study 26595347 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic decompression (n = 29)
Number of subjects: 54
Study 26595347 — intervention group
Group type: COMPARATOR
Intervention: Open decompression (n = 27)
Number of subjects: 54
Study 23889837 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Treatment (IT): 100 hours of speech and language therapy (2 hours per day, 5 days per week for 10 weeks)
Number of subjects: 30
Study 23889837 — intervention group
Group type: COMPARATOR
Intervention: Regular Treatment (RT): 100 hours of speech and language therapy (2 hours per week for 50 weeks)
Number of subjects: 30
Study 21510321 — intervention group
Group type: EXPERIMENTAL
Intervention: Lafutidine with peppermint oil (10 mg lafutidine + 0.64 mL peppermint oil)
Number of subjects: 10
Study 21510321 — intervention group
Group type: COMPARATOR
Intervention: Lafutidine alone (10 mg)
Number of subjects: 10
Study 19783777 — intervention group
Group type: EXPERIMENTAL
Intervention: LTP
Number of subjects: 55